These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiogenesis as a component of epithelial-mesenchymal interactions. Grant DS; Rose RW; Kinsella JK; Kibbey MC EXS; 1995; 74():235-48. PubMed ID: 8527897 [TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix and growth factors in branching morphogenesis. Hardman P; Spooner BS Trans Kans Acad Sci; 1993 Apr; 96(1-2):56-61. PubMed ID: 11537712 [TBL] [Abstract][Full Text] [Related]
4. Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. Ingber DE Differentiation; 2002 Dec; 70(9-10):547-60. PubMed ID: 12492496 [TBL] [Abstract][Full Text] [Related]
5. [Epithelial-mesenchymal transition in cancer progression]. Gos M; Miłoszewska J; Przybyszewska M Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467 [TBL] [Abstract][Full Text] [Related]
6. Theory for epithelial-mesenchymal transformation based on the "fixed cortex" cell motility model. Hay ED Cell Motil Cytoskeleton; 1989; 14(4):455-7. PubMed ID: 2696597 [No Abstract] [Full Text] [Related]
7. Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers. Chang JY; Wright JM; Svoboda KK Cells Tissues Organs; 2007; 185(1-3):40-7. PubMed ID: 17587806 [TBL] [Abstract][Full Text] [Related]
8. Peptide growth factors and inflammation, tissue repair, and cancer. Sporn MB; Roberts AB J Clin Invest; 1986 Aug; 78(2):329-32. PubMed ID: 3525608 [No Abstract] [Full Text] [Related]
9. Signaling networks in barrier homeostasis. The mystery widens. Elias PM; Ansel JC; Woods LD; Feingold KR Arch Dermatol; 1996 Dec; 132(12):1505-6. PubMed ID: 8961883 [No Abstract] [Full Text] [Related]
10. Epithelial-mesenchymal transitions in development and tumor progression. Birchmeier W; Birchmeier C EXS; 1995; 74():1-15. PubMed ID: 8527890 [TBL] [Abstract][Full Text] [Related]
11. NF-kappaB and epithelial to mesenchymal transition of cancer. Min C; Eddy SF; Sherr DH; Sonenshein GE J Cell Biochem; 2008 Jun; 104(3):733-44. PubMed ID: 18253935 [TBL] [Abstract][Full Text] [Related]
12. Rho proteins and cell-matrix interactions in cancer. Wu M; Wu ZF; Merajver SD Cells Tissues Organs; 2007; 185(1-3):100-3. PubMed ID: 17587814 [TBL] [Abstract][Full Text] [Related]
13. Model systems of epithelium-mesenchyme transitions. Boyer B; Vallés AM; Thiery JP Acta Anat (Basel); 1996; 156(3):227-39. PubMed ID: 9124039 [TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal interaction in gastric mucosal restoration. Watanabe S; Hirose M; Wang XE; Kobayashi O; Nagahara A; Murai T; Iwazaki R; Miwa H; Miyazaki A; Sato N J Gastroenterol; 2000; 35 Suppl 12():65-8. PubMed ID: 10779221 [TBL] [Abstract][Full Text] [Related]
15. New insights into the role of extracellular matrix during tumor onset and progression. Pupa SM; Ménard S; Forti S; Tagliabue E J Cell Physiol; 2002 Sep; 192(3):259-67. PubMed ID: 12124771 [TBL] [Abstract][Full Text] [Related]
18. A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis. Vincan E; Brabletz T; Faux MC; Ramsay RG Cells Tissues Organs; 2007; 185(1-3):20-8. PubMed ID: 17587804 [TBL] [Abstract][Full Text] [Related]
19. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806 [TBL] [Abstract][Full Text] [Related]
20. Cell tension, matrix mechanics, and cancer development. Huang S; Ingber DE Cancer Cell; 2005 Sep; 8(3):175-6. PubMed ID: 16169461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]